WTR Global Leaders 2020
Pravin Anand and Safir Anand have been recognised for the second time as the “elite of the trademark world” by WTR Global Leaders 2020. WTR Global
IPAB Allowed an Appeal and Granted A Patent to Pfizer For Tofacitinib and its Salts
The IPAB allowed an appeal and granted a Pfizer Tofacitinib patent in India and its salts (application 991/MUMNP/2003). an appeal and granted a patent
New Era for Justice Delivery
While some flaws remain, the many advantages of virtual courts mean they should become a part of how cases are heard when normalcy returns, writes Pravin
Review and Appeal – A Bird’s Eye View
This article about remedies against patent application rejection in India was first published by Managing Intellectual Property. By Arpita Kulshrestha.
Artificial Intelligence and Trends in Patenting
Read the complete article on AI in patenting and trends followed on Asia IP By Ritika Ahuja and Jasbir Singh. Artificial Intelligence, a fuel to almost
Benchmark Litigation Rankings 2020
Managing Partner Pravin Anand has been recognised as “Litigation Star – Asia Pacific 2020” by the prestigious Benchmark Litigation while ANAND
The Necessity of India’s Confidentiality Clubs
This article on confidentiality clubs in IP litigation, was first published in the Asia Business Law journal By Vaishali Mittal and Siddhanth Chamola.
Patenting Stem Cell Inventions in India- What to Expect?
This article on patentability of stem cell inventions in India, was first published by Legal Era By Nupur Maithani. Stem cells offer hope as a promising
The Indian Judiciary and Coronavirus
Read the full article on video conferencing in Indian courts during COVID-19 at Media Law International. By Tusha Malhotra and Pankhuri Malik. In 2018,
IP Litigation – The Way To Go
This article on time limits in commercial court litigation was originally published in Experts Guides. Mr. Pravin Anand and Ridhie Bajaj argue in favour
etc. whilst wrongfully claiming to be part of our firm and making false claims and allegations.